Trial confirms heart benefits of Wegovy, but is weight loss responsible – or something else?

​ Results from a landmark clinical trial this summer suggested, for the first time, that a medication given for weight loss alone could reduce the risk of heart attack, stroke or heart-related death in people with cardiovascular disease, bolstering physicians’ excitement about an already-exploding class of new medicines. Read More Breaking News, Latest News and Videos | CNN